Literature DB >> 6211089

Phosphofructokinase (PFK) deficiency due to a catalytically inactive mutant M-type subunit.

A Zenella, M Mariani, G Meola, F Fagnani, G Sirchia.   

Abstract

A case of M-type PFK deficiency due to the synthesis of a structurally abnormal and catalytically inactive M-subunit was reported. PFK activity was reduced (39% of normal) in red cells, normal in leukocytes and platelets, and absent in muscle. The red cell enzyme was not inhibited by antiserum to human muscle PFK and displayed normal biochemical properties (Km for ATP and fructose-6-phosphate, storage stability at +4 degrees C and -80 degrees C, optimum pH, electrophoretic pattern and molecular weight). The complete lack of PFK activity in muscle was confirmed on both histological preparations and muscle extracts. Double immunodiffusion analysis using an antinormal M-PFK serum revealed that the enzyme molecule was present and immunologically identical with normal, although it was catalytically inactive. The muscle abnormality was also confirmed by electromyography, ischemic exercise testing, histochemistry and electron microscopy. Moreover, PFK activity was investigated in myoblast cultures maintained up to 25 days, and it was found to be absent.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6211089     DOI: 10.1002/ajh.2830120303

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  7 in total

1.  Diagnostic evaluation of rhabdomyolysis.

Authors:  Jessica R Nance; Andrew L Mammen
Journal:  Muscle Nerve       Date:  2015-03-14       Impact factor: 3.217

2.  Kinetic properties of erythrocyte phosphofructokinase in patients with type VII glycogenosis from two families--close similarity to liver type phosphofructokinase.

Authors:  T Shimizu; N Kono; I Mineo; S Sumi; K Nonaka; S Tarui; W Koyama
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

3.  Excess purine degradation in exercising muscles of patients with glycogen storage disease types V and VII.

Authors:  I Mineo; N Kono; T Shimizu; N Hara; Y Yamada; S Sumi; K Nonaka; S Tarui
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

4.  Muscle phosphofructokinase deficiency. Biochemical and immunological studies of phosphofructokinase isozymes in muscle culture.

Authors:  M Davidson; A F Miranda; A N Bender; S DiMauro; S Vora
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

5.  Heterogeneity of the molecular lesions in inherited phosphofructokinase deficiency.

Authors:  S Vora; M Davidson; C Seaman; A F Miranda; N A Noble; K R Tanaka; E P Frenkel; S Dimauro
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

Review 6.  Hereditary human myopathies in muscle culture.

Authors:  G Meola
Journal:  Ital J Neurol Sci       Date:  1991-06

7.  Long noncoding RNA LINC00930 promotes PFKFB3-mediated tumor glycolysis and cell proliferation in nasopharyngeal carcinoma.

Authors:  Baoyu He; Hongli Pan; Fengque Zheng; Saiqiong Chen; Qingli Bie; Jinghe Cao; Rou Zhao; Jing Liang; Li Wei; Jianchao Zeng; Hui Li; Xing Cui; Yixuan Ding; Wei Chao; Tiantian Xiang; Yuhe Cheng; Gui Qiu; Shishun Huang; Libo Tang; Jiansheng Chang; Delan Luo; Jie Yang; Bin Zhang
Journal:  J Exp Clin Cancer Res       Date:  2022-02-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.